Found: 6
Select item for more details and to access through your institution.
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse".
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 24, p. 17320, doi. 10.3390/ijms242417320
- By:
- Publication type:
- Article
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-94573-y
- By:
- Publication type:
- Article
Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury.
- Published in:
- Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.777628
- By:
- Publication type:
- Article
In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071697
- By:
- Publication type:
- Article
Systemic and local immunosuppression in glioblastoma and its prognostic significance.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1326753
- By:
- Publication type:
- Article
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1326757
- By:
- Publication type:
- Article